Edition:
India

Trinity Biotech PLC (TRIB.OQ)

TRIB.OQ on NASDAQ Stock Exchange Global Select Market

5.16USD
19 Jan 2018
Change (% chg)

-- (--)
Prev Close
$5.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,138
52-wk High
$6.92
52-wk Low
$4.30

Chart for

About

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $128.62
Shares Outstanding(Mil.): 24.04
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Trinity Biotech reports Q3 earnings per share $0.063

* Q3 revenue $25.6 million versus I/B/E/S view $26.1 million Source text for Eikon: Further company coverage:

26 Oct 2017

Competitors

  Price Chg
Tosoh Corporation (4042.T) ¥2,502 -29.00
Siemens AG (SIEGn.DE) €123.82 +0.12
Johnson & Johnson (JNJ.N) $147.36 +0.44
Roche Holding Ltd. (ROG.S) CHF235.50 +1.00
Roche Holding Ltd. (RO.S) CHF238.40 +0.60
Abbott Laboratories (ABT.N) $59.31 +0.24
Bayer AG (BAYGn.DE) €104.54 +0.46
Bayer AG (BAYE.F) -- --
Thermo Fisher Scientific Inc. (TMO.N) $213.51 +1.10
Alere Inc (ALR) $1.28 --

Earnings vs. Estimates